Carealytix is a company dedicated to transforming chronic disease management through user-centric digital products designed for modern healthcare. Their mission is to provide personalized care to people living with chronic conditions by creating scalable, data-driven, and medically grounded digital solutions.

They collaborate with healthcare providers, payers, researchers, and industry partners to innovate and improve chronic care delivery. Their platform is specifically focused on kidney care but has adaptable technology for other chronic conditions as well.

Carealytix offers a comprehensive digital care platform that supports entire patient journeys, including education, health tracking, data sharing, remote monitoring, and clinical trial support.

Key products include "Mizu," a personal companion app for chronic kidney disease (CKD) with over 10,000 registered users, and "Kidney+," a telecoaching program providing lifestyle coaching and remote support for CKD patients in partnership with renal care providers.

The company ensures full regulatory compliance, being ISO-13485 certified, GDPR compliant, and offering software classified as medical devices under EU-MDR standards.

Carealytix aims to eliminate gaps in healthcare by automating clinical workflows, improving patient engagement, accelerating clinical research, leveraging data science and real-world evidence, and enabling integrated interdisciplinary care.

They focus on creating modular, scalable solutions that streamline care delivery and reduce the chronic disease burden by advancing personalized medicine and patient self-management.